Associations between blood metabolite levels and gastrointestinal cancer risk: A preliminary untargeted metabolomics study
To some extent, this study revealed the metabolomic characteristics of spleen deficiency and blood stasis toxin (PXYD) syndrome in gastrointestinal cancers. It provides the rationale for the "same treatment for different diseases" approach in PXYD syndrome of gastrointestinal cancers, and for identifying potential metabolomics-based biomarkers.
Authors
- Wenjian Zhu (ORCID: https://orcid.org/0000-0002-5292-661X)
- Tingting Zhou (ORCID: https://orcid.org/0009-0007-3880-4935)
- Qin-Chang Zhang
- Tianhao Guo (ORCID: https://orcid.org/0000-0002-8899-2328)
- Xiao Yu Wu (ORCID: https://orcid.org/0000-0002-5333-8115)
- Weixing Shen (ORCID: https://orcid.org/0000-0002-6454-3296)
- Wei Wang (ORCID: https://orcid.org/0000-0002-9861-5577)
- Liu Li (ORCID: https://orcid.org/0000-0003-2376-8162)
- Haibo Cheng (ORCID: https://orcid.org/0000-0003-3329-2225)
- Xuemeng Wang (ORCID: https://orcid.org/0000-0002-5806-5291)
- Yifan Hui (ORCID: https://orcid.org/0000-0003-0364-9449)
- Shuoqi Zhao
Institutions
- Nanjing University of Chinese Medicine (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
- Viva Biotech (China) (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-07-12
- DOI
- https://doi.org/10.4251/wjgo.v17.i7.104860
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00